• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌的新辅助化疗。减速的时机是否已经错过?

Neoadjuvant chemotherapy for gastric cancer. Has the time to decelerate the enthusiasm passed us by?

机构信息

Department of Surgery, ASST Valle Olona, Gallarate Varese, Italy..

Department of Surgery, University Hospital of Ioannina & University of Ioannina, Ioannina, Greece.

出版信息

Semin Oncol. 2020 Dec;47(6):355-360. doi: 10.1053/j.seminoncol.2020.07.003. Epub 2020 Jul 25.

DOI:10.1053/j.seminoncol.2020.07.003
PMID:32758372
Abstract

Neoadjuvant therapy for locally advanced gastric cancer is a treatment option well recognized in international guidelines. However, neither completed randomized trials nor ongoing studies (will) offer definitive answers about the efficacy of neoadjuvant therapy. With extensive experience confirming the safety and some efficacy for this approach most current studies are focused on identifying the best preoperative treatment regimen. We try to clarify if is really the time to slow down the enthusiasm about neoadjuvant approach.

摘要

新辅助治疗局部进展期胃癌在国际指南中得到广泛认可。然而,无论是已完成的随机试验还是正在进行的研究都无法提供关于新辅助治疗疗效的明确答案。大量经验证实了这种方法的安全性和一定疗效,因此目前大多数研究都集中在确定最佳术前治疗方案上。我们试图阐明现在是否真的应该放缓对新辅助治疗方法的热情。

相似文献

1
Neoadjuvant chemotherapy for gastric cancer. Has the time to decelerate the enthusiasm passed us by?胃癌的新辅助化疗。减速的时机是否已经错过?
Semin Oncol. 2020 Dec;47(6):355-360. doi: 10.1053/j.seminoncol.2020.07.003. Epub 2020 Jul 25.
2
Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.多中心 III 期随机对照临床试验研究方案,旨在评估新辅助化疗(NAC)联合新辅助腹腔镜腹腔内热化疗(NLHIPEC)序贯 R0 胃切除术后术中腹腔内热化疗(HIPEC)治疗进展期胃癌(AGC)的疗效:龙 II 试验。
BMC Cancer. 2020 Mar 17;20(1):224. doi: 10.1186/s12885-020-6701-2.
3
Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer.影像学在预测胃癌新辅助化疗反应中的作用。
World J Gastroenterol. 2014 Feb 21;20(7):1650-6. doi: 10.3748/wjg.v20.i7.1650.
4
[Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy].[新辅助治疗后膜解剖学在胃癌手术中的应用思考]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jul 25;23(7):657-660. doi: 10.3760/cma.j.cn.441530-20200430-00249.
5
[Laparoscopic gastrectomy combined with neoadjuvant chemotherapy for gastric cancer patients: from the view of the CLASS-03a trial].[腹腔镜胃切除术联合新辅助化疗治疗胃癌患者:基于CLASS-03a试验的视角]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):138-142.
6
Neoadjuvant chemotherapy in locally advanced gastric cancer: what to avoid. Preliminary analysis of a consecutive series of patients.局部进展期胃癌的新辅助化疗:应避免的事项。对一系列连续患者的初步分析。
Tumori. 2015 Sep-Oct;101(5):511-6. doi: 10.5301/tj.5000340. Epub 2015 Apr 22.
7
[Efficacy of neoadjuvant chemotherpy in patients with locally advanced gastric cancer].新辅助化疗对局部晚期胃癌患者的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Feb;16(2):166-9.
8
Neoadjuvant therapy for oesophagogastric cancer.食管癌和胃癌的新辅助治疗
Br J Surg. 2004 May;91(5):540-51. doi: 10.1002/bjs.4575.
9
[Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].[应用倾向评分匹配法对局部进展期胃癌新辅助化疗的预后分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1148-1153.
10
[Present status of clinical trials of neoadjuvant chemotherapy for gastric cancer and key points in their design].[胃癌新辅助化疗的临床试验现状及其设计要点]
Zhonghua Zhong Liu Za Zhi. 2013 Aug;35(8):636-8.

引用本文的文献

1
Is Systemic Inflammatory Response Index (SIRI) a Reliable Tool for Prognosis of Gastric Cancer Patients Without Neoadjuvant Therapy?全身炎症反应指数(SIRI)是否是未经新辅助治疗的胃癌患者预后的可靠工具?
Cureus. 2023 Mar 23;15(3):e36597. doi: 10.7759/cureus.36597. eCollection 2023 Mar.
2
In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.在接受新辅助化疗的胃癌患者中,全身炎症反应指数是一种有用的预后指标。
Pathol Oncol Res. 2021 Oct 12;27:1609811. doi: 10.3389/pore.2021.1609811. eCollection 2021.
3
Laparoscopic gastrectomy for stage II and III advanced gastric cancer: long‑term follow‑up data from a Western multicenter retrospective study.
腹腔镜胃癌根治术治疗 II 期和 III 期进展期胃癌:来自西方多中心回顾性研究的长期随访数据。
Surg Endosc. 2022 Apr;36(4):2300-2311. doi: 10.1007/s00464-021-08505-y. Epub 2021 Apr 20.
4
Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer.氟尿嘧啶、亚叶酸钙、奥沙利铂、多西他赛联合阿帕替尼新辅助治疗局部进展期胃癌的围手术期安全性和有效性
Cancer Manag Res. 2021 Mar 10;13:2279-2286. doi: 10.2147/CMAR.S304093. eCollection 2021.
5
Treatment of Gastric Cancer.胃癌的治疗
Cancers (Basel). 2020 Sep 15;12(9):2627. doi: 10.3390/cancers12092627.